Found 619 clinical trials
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare
The SARS-CoV-2 pandemic and resulting COVID-19 disease causes a substantial burden on healthcare systems. Little is known about how the infection spreads within healthcare.
- 0 views
- 19 Feb, 2024
COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)
Within this cohort, a subset of 150-250 staff members with confirmed (PCR positive) SARS-CoV-2 disease will be followed with intensive monthly testing for 6 months to determine whether antibody levels in the blood are maintained or decrease during this time.
- 0 views
- 19 Feb, 2024
Use of PCR-Sars-CoV-2 in Children
In order to clarify the current management of young sick children in France, whether or not they are cared for in community settings (nursery, schools), paediatricians have proposed an algorithm whose objective is to help define the indications for PCR-Sars-CoV-2 (https://www.infovac.fr/actualites/bulletin-special-mai-2020).
- 0 views
- 19 Feb, 2024
Surveillance of Individuals Following SARS-CoV-2 Exposure
Researchers hope this study can be used to help improve public health guidelines for quarantines, social distancing, and returning to work after a possible SARS-CoV-2 exposure. Objective To better understand how long it takes a person to develop (or not develop) an infection with the SARS-CoV-2 virus after they have …
- 0 views
- 19 Feb, 2024
Saliva as Source of Detection for SARS-CoV-2
Background Nasopharyngeal (NP) swabbing is being used to test for SARS-CoV-2 infection. For this, a swab is inserted deep into the back of the nose to collect a sample. It can cause discomfort for most people.
- 0 views
- 19 Feb, 2024
National Covid-19 Surveillance Physicians
The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.
- 0 views
- 19 Feb, 2024
Understanding Immunity to SARS-CoV-2 the Coronavirus Causing COVID-19
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
- 0 views
- 19 Feb, 2024
Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV
In COVID-19 pandemic, it is of critical importance to identify a rapid and simple diagnostic method to be used in clinical settings to timely inform and refine strategies that can prevent, control, and stop the spread of SARS-CoV-2. The 2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a qualitative, membrane-based …
- 0 views
- 19 Feb, 2024
A Longitudinal Study of COVID-19 Sequelae and Immunity
Participants in the COVID-19 group may have visits more often if they develop symptoms that suggest re-infection with SARS-CoV-2....
- 0 views
- 19 Feb, 2024
Detection of Anti-COVID-19 Antibody Levels in an Hospital Population
COVID-19 (SARS-CoV-2) infection in health professionals represent a significant criticality both for the risk of spreading the disease and for the organizational aspects that follow.
- 0 views
- 19 Feb, 2024